藏毛窦疾病非手术治疗:迈向理想治疗的一步随机对照试验
该平行随机对照试验纳入400例骶尾部藏毛窦患者,随机分为窦道内注射硬化剂与草药混合物组和经典手术切除一期缝合组,每组200例。试验组在住院时间、费用、围术期疼痛、缺勤时间和手术时间方面显著降低。结论认为该混合物注射在成本效益、缺勤时间、并发症率和围术期疼痛方面可能优于其他治疗选择。
要点
- 试验组住院时间、费用、围术期疼痛、缺勤时间和手术时间均显著低于对照组。
- 该非手术方案在成本效益和术后恢复方面可能更具优势,但需注意研究人群为无脓肿或复杂病变者。
核心结论
- 对于无脓肿或复杂病变的骶尾部藏毛窦患者,窦道内注射硬化剂与草药混合物在成本效益、缺勤时间、并发症率和围术期疼痛方面可能优于手术切除一期缝合。
研究设计与样本
- 平行随机对照试验,2013年1月至2017年1月开展,共纳入400例骶尾部藏毛窦患者,每组200例。
- 试验组接受窦道内注射硬化剂与草药(Lawsonia inermis粉末)混合物,对照组接受经典手术切除一期缝合。
- 患者年龄18至40岁,平均27.1岁(标准差±2.4),男性316例(79%),女性84例(21%)。
- 所有患者均无脓肿或复杂性藏毛窦疾病。
主要发现
- 试验组住院时间、费用、围术期疼痛、缺勤时间和手术时间均较对照组有统计学显著降低。
临床怎么用
- 对于无脓肿或复杂病变的藏毛窦患者,可考虑窦道内注射硬化剂与草药混合物作为非手术治疗选择,以缩短住院和缺勤时间、降低费用和围术期疼痛。
- 需注意该研究纳入人群为无脓肿或复杂病变者,临床应用时应评估患者是否适用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pilonidal sinus disease is a common perianal inflammatory condition. Currently, operative therapy is the standard management strategy. The aim of this study is to investigate the efficacy of a preparation with antimicrobial, sclerosing, and wound-enhancing properties in the nonoperative management of pilonidal sinus disease. METHODS: A parallel randomized controlled trial was conducted between January 2013 and January 2017 to investigate the effect of a mixture of sclerosing agent and herbal product (Lawsonia inermis powder) in the management of sacrococcygeal pilonidal sinus disease. The patients were allocated randomly into the study group (group receiving injection of the mixture into the sinus track) and the control group (group receiving the classic technique of operative excision and primary closure). RESULTS: This study was conducted among 400 patients, 316 (79%) male, 84 (21%) female. The age range was 18 to 40 years with a mean age of 27.1 years (standard deviation, ±2.4); each group included 200 patients. None of the patients had an abscess or complicated pilonidal disease. Cure rate, defined as complete healing of the sinus, was high among both groups after the first intervention (94% for control group and 89% for the test group, respectively; P = .051). In the study group, there was a statistically significant decrease in hospital stay, cost, perioperative pain, duration of absence from work, and duration of the procedure. CONCLUSION: According to this trial, the injection of this mixture appears to be better than the other therapeutic options for pilonidal sinus disease in terms of cost effectiveness, time off work, rate of complication, and perioperative pain.
引用
- Salih AM, Kakamad FH, Salih RQ, et al. Nonoperative management of pilonidal sinus disease: one more step toward the ideal management therapy-a randomized controlled trial. Surgery. 2018. PMID: 29402447. doi:10.1016/j.surg.2017.12.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。